Stifel Financial Corp (SF) Stock Analysis
Is SF a good investment?
Stifel Financial Corp (SF) has a Plutrex AI rating of 80.0/100 as of August 22, 2026, indicating a Strong Buy consensus. The stock is not classified as halal-compliant. Key strength: Extreme valuation discount with superior long-term growth: PEG 0.72 vs. industry 1.16 (37.9% cheaper) while 5-year EPS growth of 14.85% exceeds industry 14.03% — SF grows faster but trades at a 37.5% P/E discount (14.29x vs. 22.87x). If SF re-rates to even a 10% discount to peers (P/E ~20.6x), implied price is ~$117, representing ~44% upside from $80.96.. Main concern: Zero free cash flow despite 13.7% net margins remains the single most critical unresolved risk. The $0 FCF figure means the company generates no surplus cash after capex, raising questions about earnings quality, capital intensity, or working capital dynamics. The dividend declaration (payable September 15, 2026) is a positive signal but does not resolve the structural FCF question — dividends paid from a $0 FCF base imply cash reserves are being drawn down. Until FCF normalizes to a level consistent with the 13.7% net margin (implying FCF should be hundreds of millions annually), intrinsic value via DCF carries meaningful uncertainty..
Investment Summary
Stifel Financial (SF) is a high-quality investment banking and wealth management firm trading at a compelling valuation discount. At $80.96 (down 5.4% from our prior report's $85.62), the stock has become MORE attractive, not less. The core thesis is unchanged and strengthened: SF trades at P/E 14.29x with 14.85% 5-year EPS growth (PEG 0.72), while industry peers average P/E 22.87x with 14.03% growth (PEG 1.16). SF grows faster but trades 37.5% cheaper on P/E and 37.9% cheaper on PEG — a rare dual discount. The analyst consensus target of $90.14 implies 11.3% upside from current $80.96. Q2 2026 results confirmed execution: broad-based growth across wealth management, investment banking, and net interest income. The Board declared a quarterly dividend payable September 15, 2026, signaling management confidence. The CEO's commentary on AI-driven productivity gains ('AI Will Lead to Productivity Gains, Stifel CEO Says') directly addresses the structural operating margin gap (21.76% vs. industry 29.25%). The primary unresolved concern — zero free cash flow despite 13.7% net margins — remains the key risk. The 5.4% price decline since our last report has improved the risk/reward profile meaningfully, with the entry range now adjusted lower to $78.50-$82.50.
Key Strengths
- Extreme valuation discount with superior long-term growth: PEG 0.72 vs. industry 1.16 (37.9% cheaper) while 5-year EPS growth of 14.85% exceeds industry 14.03% — SF grows faster but trades at a 37.5% P/E discount (14.29x vs. 22.87x). If SF re-rates to even a 10% discount to peers (P/E ~20.6x), implied price is ~$117, representing ~44% upside from $80.96.
- Q2 2026 execution confirmed with broad-based growth: 'Stifel Reports Second Quarter 2026 Results' and 'Stifel Financial Q2 Earnings Call Highlights' confirm growth across wealth management, investment banking, AND net interest income — three distinct revenue streams growing simultaneously reduces concentration risk. Dividend declared payable September 15, 2026 signals management confidence in cash generation.
- Fortress balance sheet with strategic optionality: D/E of 0.32 is 36.5% below industry average, $5.22 billion cash provides M&A/buyback capacity. Revenue growth of 12.7% outpaces industry by 15.9%. CEO's AI productivity commentary ('AI Will Lead to Productivity Gains, Stifel CEO Says') suggests a credible path to narrowing the 748 bps operating margin gap vs. peers — if operating margin improves from 21.76% toward 25%, EPS could accelerate meaningfully above the 15.07% consensus.
Key Concerns
- Zero free cash flow despite 13.7% net margins remains the single most critical unresolved risk. The $0 FCF figure means the company generates no surplus cash after capex, raising questions about earnings quality, capital intensity, or working capital dynamics. The dividend declaration (payable September 15, 2026) is a positive signal but does not resolve the structural FCF question — dividends paid from a $0 FCF base imply cash reserves are being drawn down. Until FCF normalizes to a level consistent with the 13.7% net margin (implying FCF should be hundreds of millions annually), intrinsic value via DCF carries meaningful uncertainty.
- Operating margin of 21.76% is 748 bps below industry average of 29.25% — a structural cost disadvantage that creates earnings vulnerability if revenue growth decelerates. The 65.7 percentage point spread between gross margin (87.47%) and operating margin (21.76%) means SF's operating expenses consume an outsized share of revenue. Near-term EPS growth of 15.07% already lags industry 17.06% by 199 bps, and any revenue slowdown would compress earnings faster than peers given this cost structure. The 5.4% stock price decline since our prior report ($85.62 → $80.96) may partially reflect market recognition of this near-term growth shortfall.
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
SF's fundamentals present a high-quality business at a value price. Profitability: Gross margin of 87.5% reflects an asset-light, high-pricing-power model. Operating margin of 21.76% lags industry average of 29.25% by 748 bps — the most significant structural weakness. Net margin of 13.70% actually beats industry average of 12.69% by 101 bps, suggesting favorable below-the-line items (lower interest expense from D/E of 0.32 vs. industry 0.50). ROE of 16.43% exceeds Buffett's 15% threshold but lags industry average of 25.51% by 910 bps — partially explained by lower leverage. Valuation: P/E of 14.29x vs. industry 22.87x (37.5% discount). PEG of 0.72 vs. industry 1.16 (37.9% discount) — investors pay 72 cents per dollar of growth vs. $1.16 for peers. Price-to-Book of 2.27x is reasonable for 16.43% ROE. Growth: Revenue growth of 12.7% exceeds industry average of 10.96% by 159 bps. Next-year EPS growth of 15.07% slightly lags industry 17.06% by 199 bps, but 5-year EPS growth of 14.85% exceeds industry 14.03% by 82 bps — SF's growth advantage compounds over time. Financial Health: D/E of 0.32 is 36.5% below industry average of 0.50. Cash of $5.22 billion provides substantial liquidity. Critical concern: Free cash flow of $0 despite 13.7% net margins — this earnings-to-cash conversion gap is the single most important unresolved risk and limits DCF-based intrinsic value confidence.
News Sentiment
Stifel Financial is firing on all cylinders heading into the second half of 2026, with the St. Louis-based investment bank reporting strong second-quarter results that beat expectations across the board. The company's Q2 earnings call highlighted what executives called 'broad-based growth' — a rare achievement where wealth management, investment banking, AND net interest income all grew simultaneously, suggesting the business isn't dependent on any single revenue engine. In a move that signals management's confidence in the company's financial health, Stifel's board declared its quarterly common stock cash dividend, payable September 15, 2026 to shareholders of record as of September 1. The company also declared a preferred stock dividend in the same announcement. Perhaps most intriguing for long-term investors is CEO Ronald James Kruszewski's bullish stance on artificial intelligence. 'AI Will Lead to Productivity Gains,' Kruszewski told analysts — a statement that carries real weight for a firm that has historically struggled with operating costs relative to peers. If AI tools can help Stifel close even part of its 748 basis-point operating margin gap versus industry competitors, the earnings impact could be substantial. Meanwhile, Stifel's research arm continues to generate market attention, with its analysts issuing a Buy rating on Custom Health — which promptly sealed a pharmacy deal, validating Stifel's research credibility. The overall picture: a well-capitalized, growing financial services firm trading at a significant discount to peers, with management actively pursuing efficiency improvements that could unlock meaningful shareholder value.
Risk Assessment
PRIMARY RISK: Zero free cash flow is the most critical concern. If FCF remains at $0 for multiple quarters, it suggests either (a) heavy capital reinvestment that will eventually generate returns, or (b) structural earnings quality issues where reported net income doesn't convert to cash. Mitigation: The $5.22 billion cash position provides a multi-year buffer even at moderate cash burn rates. SECONDARY RISK: Operating margin gap of 748 bps vs. industry peers creates earnings sensitivity to revenue deceleration. If revenue growth slows from 12.7% toward 8-9%, operating leverage works in reverse and EPS growth could fall below the 15.07% consensus. Mitigation: CEO's AI productivity commentary suggests awareness and active management of this gap. MARKET RISK: The 5.4% price decline since our prior report ($85.62 → $80.96) occurred without apparent fundamental deterioration — this may reflect broader market weakness or sector rotation. Stop loss at $74.00 (8.1% below entry midpoint of $80.50) limits downside if the FCF concern proves more serious than anticipated. UPSIDE SCENARIO: If SF re-rates to a 20% P/E discount to peers (vs. current 37.5% discount), implied P/E would be ~18.3x, implying a price of ~$104 — representing 28% upside from current levels. The 5-year EPS growth advantage over peers (14.85% vs. 14.03%) provides the fundamental catalyst for this re-rating.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is SF a halal stock?
No, Stifel Financial Corp (SF) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for SF?
Stifel Financial Corp (SF) has a Plutrex AI rating of 80.0/100 with a Strong Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is SF a good investment?
According to Plutrex AI, SF has a Strong Buy rating (80.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in SF?
US stocks like SF can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in SF?
Plutrex AI identifies the main risks for SF by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.